{"id":380158,"date":"2020-11-12T15:39:08","date_gmt":"2020-11-12T20:39:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380158"},"modified":"2020-11-12T15:39:08","modified_gmt":"2020-11-12T20:39:08","slug":"ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/","title":{"rendered":"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index"},"content":{"rendered":"

<\/p>\n

IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index<\/b><\/p>\n

Annualized 2020 Return Since IBBJ\u2019s Launch is 100.87% vs Nasdaq Biotech TR Index 5.77%<\/i><\/p>\n

\nIBBJ 20.83% (since inception) vs. Nasdaq Biotechnology TR Index 1.53%\n<\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nAbout Defiance: Founded in 2018, Defiance ETFs is an exchange-traded funds (ETFs) sponsor and registered investment advisor, focused on thematic investing. Defiance\u2019s organic growth, driven by our innovative first-mover ETFs and cutting-edge digital footprint, has made Defiance into one of the most dynamic investment brands. Our suite of rules-based ETFs allows retail investors, financial advisors and institutions to express a targeted view on subsectors that are leading the way in disruptive innovations. Defiance\u2019s growth and digital reach in asset management is powered by its proprietary digital marketing technology, Defiance Analytics LLC. Analytics utilizes machine learning and natural language processing to enhance investors\u2019 digital experience around product research and content.\n<\/p>\n

\nIndex Description: The Nasdaq Junior Biotechnology Index is designed to track the performance of a set of securities that are classified as either biotechnology or pharmaceutical. To be eligible for inclusion in the Index, a security must meet the following criteria: 1) Be a member of the Nasdaq Biotechnology Index. 2) Have a market capitalization that is less than $5 billion as of the reference date of the annual evaluation.\n<\/p>\n

\nPerformance as of 11\/11\/2020.
\n
Performance since Inception of IBBJ: 8\/4\/2020. Source: Bloomberg.\n<\/p>\n

\nFor additional information, please visit www.DefianceETFs.com<\/a> or call 1-833-333-9383.\n<\/p>\n

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month-end can be obtained by calling 833.333.9383 or by going to this link: https:\/\/www.defianceetfs.com\/ibbj.<\/a><\/b>Short term performance, in particular, is not a good indication of the fund’s future performance, and an investment should not be made based solely on returns.\n<\/p>\n

The Fund\u2019s investment objectives, risks, charges, and expenses must be considered carefully before investing. The prospectus and summary prospectus contain this and other important information about the investment company. The prospectus can be obtained by calling 1-833-333-9383 Please read it carefully before investing. <\/i><\/p>\n

Investing involves risk. Principal loss is possible. <\/b><\/p>\n

\nA commission may apply when buying or selling an ETF.\n<\/p>\n

\nThe Fund is new with a limited operating history.\n<\/p>\n

\nDefiance ETFs are distributed by Foreside Fund Services, LLC.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201112006046\/en\/<\/a><\/span><\/p>\n

\nDavid Hanono
\n
Defiance ETFs
\n
1-833-333-9393
\n
info@defianceetfs.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America New York<\/p>\n

INDUSTRY KEYWORDS:<\/b> Professional Services Health Finance Banking Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index Annualized 2020 Return Since IBBJ\u2019s Launch is 100.87% vs Nasdaq Biotech TR Index 5.77% IBBJ 20.83% (since inception) vs. Nasdaq Biotechnology TR Index 1.53% NEW YORK–(BUSINESS WIRE)– About Defiance: Founded in 2018, Defiance ETFs is an exchange-traded funds (ETFs) sponsor and registered investment advisor, focused on thematic investing. Defiance\u2019s organic growth, driven by our innovative first-mover ETFs and cutting-edge digital footprint, has made Defiance into one of the most dynamic investment brands. Our suite of rules-based ETFs allows retail investors, financial advisors and institutions to express a targeted view on subsectors that are leading the way in disruptive innovations. Defiance\u2019s growth and digital reach in asset management is powered by … <\/p>\n

Continue reading “IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-380158","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nIBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index Annualized 2020 Return Since IBBJ\u2019s Launch is 100.87% vs Nasdaq Biotech TR Index 5.77% IBBJ 20.83% (since inception) vs. Nasdaq Biotechnology TR Index 1.53% NEW YORK–(BUSINESS WIRE)– About Defiance: Founded in 2018, Defiance ETFs is an exchange-traded funds (ETFs) sponsor and registered investment advisor, focused on thematic investing. Defiance\u2019s organic growth, driven by our innovative first-mover ETFs and cutting-edge digital footprint, has made Defiance into one of the most dynamic investment brands. Our suite of rules-based ETFs allows retail investors, financial advisors and institutions to express a targeted view on subsectors that are leading the way in disruptive innovations. Defiance\u2019s growth and digital reach in asset management is powered by … Continue reading "IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T20:39:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201112006046r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index\",\"datePublished\":\"2020-11-12T20:39:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/\"},\"wordCount\":472,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201112006046r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/\",\"name\":\"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201112006046r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-11-12T20:39:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201112006046r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201112006046r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/","og_locale":"en_US","og_type":"article","og_title":"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index - Market Newsdesk","og_description":"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index Annualized 2020 Return Since IBBJ\u2019s Launch is 100.87% vs Nasdaq Biotech TR Index 5.77% IBBJ 20.83% (since inception) vs. Nasdaq Biotechnology TR Index 1.53% NEW YORK–(BUSINESS WIRE)– About Defiance: Founded in 2018, Defiance ETFs is an exchange-traded funds (ETFs) sponsor and registered investment advisor, focused on thematic investing. Defiance\u2019s organic growth, driven by our innovative first-mover ETFs and cutting-edge digital footprint, has made Defiance into one of the most dynamic investment brands. Our suite of rules-based ETFs allows retail investors, financial advisors and institutions to express a targeted view on subsectors that are leading the way in disruptive innovations. Defiance\u2019s growth and digital reach in asset management is powered by … Continue reading \"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T20:39:08+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201112006046r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index","datePublished":"2020-11-12T20:39:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/"},"wordCount":472,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201112006046r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/","name":"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201112006046r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-11-12T20:39:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201112006046r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201112006046r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibbj-etf-the-junior-biotech-etf-outperforming-nasdaq-biotechnology-index\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=380158"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380158\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=380158"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=380158"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=380158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}